Our portfolio

Acquired by 23andMe

Acquired by ProPhase Labs

Acquired by Stanley Black & Decker

Acquired by ResMed

Acquired by Aktana

Acquired by Cambridge Cognition

Related portfolio news

Hikma Ventures leads Series B extension in Activ Surgical to support the global commercialization of its platform
22 March 2022
Hikma Ventures leads Series A extension in NuvoAir to support its platform for patient-centric care and clinical trials
19 January 2022
Hikma Ventures invests in biotechnology company BioSapien Inc., developer of a patented drug-delivery device intended to reduce the system-wide side effects of chemotherapy treatments
11 November 2021